These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Gangliosides. Their role in clinical neurology. Nobile-Orazio E; Carpo M; Scarlato G Drugs; 1994 Apr; 47(4):576-85. PubMed ID: 7516857 [TBL] [Abstract][Full Text] [Related]
9. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [TBL] [Abstract][Full Text] [Related]
18. Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association. Granieri E; Casetta I; Govoni V; Tola MR; Paolino E; Rocca WA Neuroepidemiology; 1991; 10(4):161-9. PubMed ID: 1745325 [TBL] [Abstract][Full Text] [Related]
19. Gangliosides and Guillain-Barré syndrome: the Spanish data. Díez-Tejedor E; Gutiérrez-Rivas E; Gil-Peralta A Neuroepidemiology; 1993; 12(5):251-6. PubMed ID: 8309499 [TBL] [Abstract][Full Text] [Related]